Pipeline

A continuously expanding multi-asset pipeline.

Each Telanode is built and operated within Thelamux. Active today, with selective near-term expansion underway.

Telanode Asset Stage Status
Telanode 1
Tethra Biosciences		 plogosertib (THT-140)
Solid tumors		 Phase 1/2 Active
Telanode 1
Tethra Biosciences		 plogosertib (THT-140)
Hematology		 Phase 1/2 Planned
Telanode 2
In active evaluation		 — — Sourcing
Telanode 3+
Continuous platform sourcing		 — — Pipeline

All clinical assets carry technical and regulatory risk. Asset-level data and pipeline detail available to qualified parties under NDA.

How we build

Disciplined sourcing, rapid activation, parallel scale.

The Thelamux pipeline is engineered to expand without rebuilding infrastructure for every asset.

Source

Underutilized assets.

License or acquire globally — pharma-shelved or undercapitalized programs with differentiated mechanisms and existing data.

Activate

Plug into shared infrastructure.

Each Telanode launches on the THELA + MUX operating system on day one — clinical, regulatory, CMC, translational — inherited, not rebuilt.

Scale

Parallel development.

Multiple programs run in parallel without proportional cost increases. Portfolio-level learning compounds across every Telanode.

Want detail on a specific Telanode?

Asset-level data, mechanism, and clinical timing are available to qualified parties under NDA.

Get in touch